These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 27618908)

  • 101. Dietary consumption and serum pattern of bioactive fatty acids in NAFLD patients.
    López-Bautista F; Barbero-Becerra VJ; Ríos MY; Ramírez-Cisneros MÁ; Sánchez-Pérez CA; Ramos-Ostos MH; Uribe M; Chávez-Tapia NC; Juárez-Hernández E
    Ann Hepatol; 2020; 19(5):482-488. PubMed ID: 32717363
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Quantification of Hepatic Fat Fraction in Patients With Nonalcoholic Fatty Liver Disease: Comparison of Multimaterial Decomposition Algorithm and Fat (Water)-Based Material Decomposition Algorithm Using Single-Source Dual-Energy Computed Tomography.
    Zhang Q; Zhao Y; Wu J; Xie L; Chen A; Liu Y; Song Q; Li J; Wu T; Xie L; Liu A
    J Comput Assist Tomogr; 2021 Jan-Feb 01; 45(1):12-17. PubMed ID: 33186174
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Novel equation to determine the hepatic triglyceride concentration in humans by MRI: diagnosis and monitoring of NAFLD in obese patients before and after bariatric surgery.
    Jiménez-Agüero R; Emparanza JI; Beguiristain A; Bujanda L; Alustiza JM; García E; Hijona E; Gallego L; Sánchez-González J; Perugorria MJ; Asensio JI; Larburu S; Garmendia M; Larzabal M; Portillo MP; Aguirre L; Banales JM
    BMC Med; 2014 Aug; 12():137. PubMed ID: 25164060
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Feasibility of assessing liver lipid by proton magnetic resonance spectroscopy in healthy normal and overweight prepubertal children.
    Larson-Meyer DE; Newcomer BR; VanVrancken-Tompkins CL; Sothern M
    Diabetes Technol Ther; 2010 Mar; 12(3):207-12. PubMed ID: 20151771
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Impact of a Mediterranean diet on hepatic and metabolic outcomes in non-alcoholic fatty liver disease: The MEDINA randomised controlled trial.
    George ES; Reddy A; Nicoll AJ; Ryan MC; Itsiopoulos C; Abbott G; Johnson NA; Sood S; Roberts SK; Tierney AC
    Liver Int; 2022 Jun; 42(6):1308-1322. PubMed ID: 35357066
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Short-Term Variability of Proton Density Fat Fraction in Pancreas and Liver Assessed by Multiecho Chemical-Shift Encoding-Based MRI at 3 T.
    Machann J; Hasenbalg M; Dienes J; Wagner R; Sandforth A; Fritz V; Birkenfeld AL; Nikolaou K; Kullmann S; Schick F; Heni M
    J Magn Reson Imaging; 2022 Oct; 56(4):1018-1026. PubMed ID: 35084802
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Dietary n-3 and n-6 fatty acid intakes and NAFLD: A cross-sectional study in the United States.
    Cui J; Li L; Ren L; Sun J; Zhao H; Sun Y
    Asia Pac J Clin Nutr; 2021; 30(1):87-98. PubMed ID: 33787044
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Liver fat scores do not reflect interventional changes in liver fat content induced by high-protein diets.
    Kabisch S; Markova M; Hornemann S; Sucher S; Pivovarova-Ramich O; Machann J; Hierholzer J; Rohn S; Pfeiffer AFH
    Sci Rep; 2021 Apr; 11(1):8843. PubMed ID: 33893355
    [TBL] [Abstract][Full Text] [Related]  

  • 109. The GH/IGF-1 Axis Is Associated With Intrahepatic Lipid Content and Hepatocellular Damage in Overweight/Obesity.
    Dichtel LE; Corey KE; Haines MS; Chicote ML; Kimball A; Colling C; Simon TG; Long MT; Husseini J; Bredella MA; Miller KK
    J Clin Endocrinol Metab; 2022 Aug; 107(9):e3624-e3632. PubMed ID: 35779256
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Metabolic effects of a prolonged, very-high-dose dietary fructose challenge in healthy subjects.
    Smajis S; Gajdošík M; Pfleger L; Traussnigg S; Kienbacher C; Halilbasic E; Ranzenberger-Haider T; Stangl A; Beiglböck H; Wolf P; Lamp T; Hofer A; Gastaldelli A; Barbieri C; Luger A; Trattnig S; Kautzky-Willer A; Krššák M; Trauner M; Krebs M
    Am J Clin Nutr; 2020 Feb; 111(2):369-377. PubMed ID: 31796953
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Liver fat accumulation is associated with reduced hepatic insulin extraction and beta cell dysfunction in healthy older individuals.
    Finucane FM; Sharp SJ; Hatunic M; Sleigh A; De Lucia Rolfe E; Aihie Sayer A; Cooper C; Griffin SJ; Wareham NJ
    Diabetol Metab Syndr; 2014 Mar; 6(1):43. PubMed ID: 24669786
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Effect of resistance training on non-alcoholic fatty-liver disease a randomized-clinical trial.
    Zelber-Sagi S; Buch A; Yeshua H; Vaisman N; Webb M; Harari G; Kis O; Fliss-Isakov N; Izkhakov E; Halpern Z; Santo E; Oren R; Shibolet O
    World J Gastroenterol; 2014 Apr; 20(15):4382-92. PubMed ID: 24764677
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Short-term Dietary Interventions for the Management of Nonalcoholic Fatty Liver.
    Stokes CS; Lammert F; Krawczyk M
    Curr Med Chem; 2019; 26(19):3483-3496. PubMed ID: 28482789
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Intrahepatic Fat Content and COVID-19 Lockdown in Adults with NAFLD and Metabolic Syndrome.
    Montemayor S; Mascaró CM; Ugarriza L; Casares M; Gómez C; Martínez JA; Tur JA; Bouzas C
    Nutrients; 2022 Aug; 14(17):. PubMed ID: 36079720
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Association between ectopic pancreatic and hepatic fat and metabolic risk factors in children with non-alcoholic fatty liver disease.
    Lee EH; Kim JY; Yang HR
    Pediatr Obes; 2021 Oct; 16(10):e12793. PubMed ID: 33942524
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Hepatic saturated fatty acid fraction is associated with de novo lipogenesis and hepatic insulin resistance.
    Roumans KHM; Lindeboom L; Veeraiah P; Remie CME; Phielix E; Havekes B; Bruls YMH; Brouwers MCGJ; Ståhlman M; Alssema M; Peters HPF; de Mutsert R; Staels B; Taskinen MR; Borén J; Schrauwen P; Schrauwen-Hinderling VB
    Nat Commun; 2020 Apr; 11(1):1891. PubMed ID: 32312974
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Effect of recombinant human growth hormone on liver fat content in young adults with nonalcoholic fatty liver disease.
    Pan CS; Weiss JJ; Fourman LT; Buckless C; Branch KL; Lee H; Torriani M; Misra M; Stanley TL
    Clin Endocrinol (Oxf); 2021 Feb; 94(2):183-192. PubMed ID: 33037656
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Change and 1-year maintenance of nutrient and food group intakes at a 12-week worksite dietary intervention trial for men at high risk of coronary heart disease.
    Sasaki S; Ishikawa T; Yanagibori R; Amano K
    J Nutr Sci Vitaminol (Tokyo); 2000 Feb; 46(1):15-22. PubMed ID: 10868348
    [TBL] [Abstract][Full Text] [Related]  

  • 119. The influence of dietary fatty acids on liver fat content and metabolism.
    Hodson L; Rosqvist F; Parry SA
    Proc Nutr Soc; 2020 Feb; 79(1):30-41. PubMed ID: 30942685
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Association between Dietary Patterns and Non-alcoholic Fatty Liver Disease: Results from a Case-Control Study.
    Tutunchi H; Saghafi-Asl M; Asghari-Jafarabadi M; Ostadrahimi A
    Arch Iran Med; 2021 Jan; 24(1):35-42. PubMed ID: 33588566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.